|
⚲
|
| Keyboard |
| Storgard Chris
✚
|
|
|---|---|
| CIK # | 0001674703 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001674703] | |
| 4 | [0001674703] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Design Therapeutics Inc | |
| Storgard Chris | |
| Fate Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Design Therapeutics Inc DSGN
Stock option (right to buy) · derivative
|
2026-01-02 | Grant | 250,000 | $0.00 | |
|
Design Therapeutics Inc DSGN
Stock Option (right to buy) · derivative
|
2025-05-01 | Grant | 400,000 | $0.00 | |
|
Fate Therapeutics Inc FATE
Stock Option (right to buy) · derivative
|
2018-01-16 | Grant | 186,000 | ||
|
Fate Therapeutics Inc FATE
Stock Option (right to buy) · derivative
|
2017-01-04 | Grant | 150,000 | ||
|
Fate Therapeutics Inc FATE
Common Stock
|
2016-11-23 | Buy | 37,593 | $2.66 | 99,997 |
|
Fate Therapeutics Inc FATE
Common Stock
|
2016-05-16 | Grant | 9,090 | $0.00 | |
|
Fate Therapeutics Inc FATE
Stock option (right to buy) · derivative
|
2016-05-16 | Grant | 200,000 |